BB
Benjamin Burnett Stifel Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Xenon Pharmaceuticals
XENE
$2.98B
| $38.64 | $48 |
24%
upside
| Overweight | 2 days ago |
|
2
Axsome Therapeutics
AXSM
$6.21B
| $124.41 | $163 |
31%
upside
| Overweight | 2 days ago |
|
|
CNTA
3
Centessa Pharmaceuticals
CNTA
$2.12B
| $15.79 | $31 |
96%
upside
| Overweight | 2 days ago |
|
|
AVDL
4
Avadel Pharmaceuticals
AVDL
$1.46B
| $14.99 | $16 |
7%
upside
| Equal-Weight | 2 days ago |
|
5
Alkermes
ALKS
$4.77B
| $28.92 | $44 |
52%
upside
| Overweight | 2 days ago |
|
6
Revolution Medicines
RVMD
$7.28B
| $38.95 | $64 |
64%
upside
| Buy | 5 months ago |
|
7
CRISPR Therapeutics
CRSP
$4.8B
| $52.74 | $49 |
7%
downside
| Hold | 6 months ago |
|
8
Disc Medicine
IRON
$2.09B
| $60.19 | $94 |
56%
upside
| Buy | 7 months ago |
|
9
Arcellx
ACLX
$4B
| $72.16 | $122 |
69%
upside
| Buy | 10 months ago |
|
10
Beam Therapeutics
BEAM
$1.88B
| $18.54 | $69 |
272%
upside
| Buy | 11 months ago |
|
11
IDEAYA Biosciences
IDYA
$2.26B
| $25.83 | $68 |
163%
upside
| Buy | 1 year ago |
|
12
Precigen
PGEN
$1.36B
| $4.56 | $10 |
119%
upside
| Buy | 1 year ago |
|
13
Iovance Biotherapeutics
IOVA
$796M
| $2.20 | $25 |
1,036%
upside
| Buy | 2 years ago |
|
14
Nektar Therapeutics
NKTR
$684M
| $35.98 | $360 |
901%
upside
| Buy | 4 years ago |
|